Five Prime Therapeutics, Inc. Gains 237.08%
Wed, Nov 11, 2020 at 05:30 PM
Five Prime Therapeutics, Inc. (FPRX:NASDAQ) shot up at $18, a gain of 237.1%. On Tue 10 Nov 20, FPRX:NASDAQ hit a New 2-Week Intraday High of $5.64. The stock got featured on our News Catalysts scanner on Wed 11 Nov 20 at 05:28 PM in the 'PUBLIC OFFERING' category. From Tue 27 Oct 20, the stock recorded 50.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Five Prime Therapeutics, Inc. (FPRX:NASDAQ)
Five Prime Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in discovering & developing novel protein therapeutics to improve lives of patients with serious diseases.
Top 10 Gainers:
- Five Prime Therapeutics, Inc. (FPRX:NASDAQ), 237.08%
- Fuel Tech, Inc. (FTEK:NASDAQ), 64.26%
- Equillium, Inc. (EQ:NASDAQ), 44.83%
- GRAY (GRAY:NASDAQ), 35.27%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 34.66%
- Genfit SA (GNFT:NASDAQ), 28.79%
- Immuron Limited (IMRN:NASDAQ), 24.44%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 24.02%
- Revlon, Inc. (REV:NYSE), 22.53%
- Celcuity Inc. (CELC:NASDAQ), 22.03%